Back to calendar
Metagenomi Therapeutics, Inc. (MGX) Earnings
MGX reports earnings on Wednesday, November 18, 2026
earnings report
November 18, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.64
Actual EPS: $-0.73
EPS surprise: -31.99%
Company overview
Market Cap$29.1M
PriceUSD 0.77
EPS (TTM)-2.49
52-week high2.28
52-week low0.72
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees119